Capital With Codeine

   
Google
 
Web NewDrugInformation.com

Capital With Codeine


Drug - Capital With Codeine
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Acetaminophen; Codeine Phosphate
Multiple ingredients are in alphabetical order.

Strength - 325MG;30MG
The potency of the active ingredient(s), Acetaminophen; Codeine Phosphate. May repeat for multiple part products.

Applicant - CARNRICK
The firm name holding legal responsibility for Capital With Codeine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 083643
The FDA assigned number to Capital With Codeine. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Capital With Codeine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Capital With Codeine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Capital With Codeine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Capital With Codeine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Carnrick Laboratories Inc Div Gw Carnrick Co
The full name of the firm holding legal responsibility for the new application of Capital With Codeine.

Capital With Codeine